Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001240186 | SCV001413111 | pathogenic | Maple syrup urine disease | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly296Glufs*9) in the BCKDHB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BCKDHB are known to be pathogenic (PMID: 16786533, 22593002). This variant is present in population databases (rs398124599, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with BCKDHB-related conditions. ClinVar contains an entry for this variant (Variation ID: 96616). For these reasons, this variant has been classified as Pathogenic. |
Elsea Laboratory, |
RCV001240186 | SCV001424185 | uncertain significance | Maple syrup urine disease | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001240186 | SCV002033123 | likely pathogenic | Maple syrup urine disease | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004566971 | SCV004215940 | pathogenic | Maple syrup urine disease type 1A | 2024-02-29 | criteria provided, single submitter | clinical testing |